HBV DNA, quantitative HBsAg and HBeAg status on tenofovir
then every 6 months
tests per year, UK, before starting, at 12, 24 and 48 weeks, then every 6 months
“Monitor HBV DNA and quantitative HBsAg levels and HBeAg status before starting tenofovir disoproxil, 12, 24 and 48 weeks after starting treatment and then every 6 months to determine treatment response and medicines adherence.”
NICE CG165, Hepatitis B (chronic): diagnosis and management, recommendation 1.6.16, 2017-10-20
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- The same schedule applies to entecavir and lamivudine (1.6.13). First year has 3 tests after the baseline.
Used in
Kept as evidence; no figure on the platform is computed from it yet.